Christina M. Parrinello
Dr. Parrinello owns Pine Mountain Consulting, LLC and works as an epidemiologist and independent consultant. She has worked with a variety of real-world and observational data sources, including prospective and retrospective epidemiologic cohort studies, registries, hospital discharge data, complex survey data, and electronic medical records. Her work has resulted in manuscripts, scientific presentations, and white papers. She has expertise in identification of data sources, literature review, study design, data insights through analytics, scientific writing, and data visualization. Her most recent role was as a Senior Quantitative Scientist at Flatiron Health, where she applied her background in study design and data analysis to inform development of real-world endpoints. Prior to that, she had a postdoctoral faculty position at Albert Einstein College of Medicine in the Department of Epidemiology, where she conducted health outcomes research to better understand novel risk factors for diabetes and cardiovascular disease.
- PhD, Epidemiology, Johns Hopkins Bloomberg School of Public Health
- MPH, Epidemiology, Columbia University Mailman School of Public Health
- BA, Biology and American Studies, Cornell University
Zhang Q, Gossai A, Monroe S, Nussbaum NC, Parrinello CM. Validation analysis of a composite real-world mortality endpoint for patients with cancer in the US. Health Services Research. [In press]
Huang Bartlett C, Mardekian J, Cotter MJ, Huang X, Zhang Z, Parrinello CM, Bourla AB. Concordance of real-world versus conventional progression-free survival from a phase 3 trial of endocrine therapy as first-line treatment for metastatic breast cancer. PLOS One. 2020 Apr;15(4): e0227256. PMID:32315295
Parrinello CM, Hua S, Carnethon MR, Gallo LC, Hudson BI, Goldberg RB, Delamater AM, Kaplan RC, Isasi CR. Associations of hyperglycemia and insulin resistance with biomarkers of endothelial dysfunction in Hispanic/Latino youths: Results from the Hispanic Community Children’s Health Study/Study of Latino Youth (SOL Youth). J Diabetes Complications. 2017 May;31(5):836-42. PMID:28242270.
Parrinello CM, Sharrett AR, Maruthur NM, Bergenstal RM, Grams ME, Coresh J, Selvin E. Racial differences in and prognostic value of biomarkers of hyperglycemia. Diabetes Care. 2016 Apr;39(4):589-95. PMID: 26681712, PMCID: PMC4806772.
Parrinello CM, Lutsey PL, Couper D, Eckfeldt JH, Steffes MW, Coresh J, Selvin E. Total short-term variability in biomarkers of hyperglycemia in older adults. Clin Chem. 2015 Dec;61(12):1540-1. PMID:26503966, PMCID:PMC4767164.
Parrinello CM, Lutsey PL, Ballantyne CM, Folsom AR, Pankow JS, Selvin E. Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality. Am Heart J. 2015 Aug;170(2):380-89. PMID:26299237, PMCID:PMC4548857.
Selvin E, Parrinello CM, Sacks DB, Coresh J. Trends in prevalence and control of diabetes in the U.S., 1988-1994 and 1999-2010. Ann Intern Med. 2014 Apr;160(8):517-25. PMID:24733192. PMCID: PMC4442608.
Parrinello CM, Landay AL, Hodis HN, Gange SJ, Norris PJ, Young M, Anastos K, Tien PC, Xue X, Lazar J, Benning L, Tracy RP, Kaplan RC. Treatment-related changes in serum lipids and inflammation: clinical relevance remains unclear. Analyses from the Women’s Interagency HIV Study. AIDS. 2013 Jun;27(9):1516-9. PMID:23435295, PMCID:PMC3909663.
Parrinello CM, Landay AL, Hodis HN, Gange SJ, Norris PJ, Young M, Anastos K, Tien PC, Xue, X, Lazar J, Benning L, Tracy RP, Kaplan RC. Association of lipid levels with HIV infection, treatment, inflammatory biomarkers and subclinical atherosclerosis in the Women’s Interagency HIV Study. Atherosclerosis. 2012 Dec;225(2):408-11. PMID:23089369, PMCID:PMC3696584.